Some advanced gene-targeting drugs would stay out of Medicare price negotiation longer. This bill moves them from a 7-year wait to an 11-year wait. It does not change the rest of the Medicare negotiation program.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Maintaining Investments in New Innovation Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Latest action on H.R. 1672: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who this affects: This bill mainly affects drug companies that make advanced gene-targeting medicines, Medicare, and patients who use or may use these drugs. Drug makers could get more time before Medicare price talks begin. Medicare could have to wait longer to try to negotiate lower prices on these products. Patients could be affected indirectly, but the bill does not say exactly how it would change their own costs or access.
Why this matters: This bill matters because it could delay when Medicare tries to lower prices for some very advanced drugs. That timing can affect drug company revenue, research plans, and Medicare spending. Supporters see that delay as a way to protect investment in risky new treatments. Critics see it as a longer wait before Medicare can push for lower prices. The bill changes timing rules, not the basic program or any direct patient price cap.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
